Vasomedical, Inc.

Cardiovascular disease-focused company reports revenues of $3.5 million in Q1 2006

Published in Cardiovascular Business Week, November 15th, 2005

Vasomedical, Inc. (VASO), a company involved in the noninvasive treatment and management of cardiovascular diseases, announced financial results for the three months ended August 31, 2005.

For the first quarter of fiscal 2006, Vasomedical recorded total revenues of $3.5 million, compared with total revenues of $4.8 for the first quarter of fiscal 2005. The company reported a net loss of $0.9 million for the 3 months ended August 31, 2005, which was approximately equal to the net loss of $0.9 million in the year-ago quarter.

For the quarter ended August 31, 2005, the company recorded a $0.8 million preferred stock dividend reflecting beneficial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2005-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry